Suppurative osteomyelitis, bisphosphonate induced osteonecrosis, osteoradionecrosis: a blinded histopathologic comparison and its implications for the mechanism of each disease

被引:87
作者
Marx, R. E. [1 ]
Tursun, R. [1 ]
机构
[1] Univ Miami, Miller Sch Med, Div Oral & Maxillofacial Surg, Coral Gables, FL 33124 USA
关键词
bisphosphonates; osteomyelitis; osteonecrosis; osteoradionecrosis;
D O I
10.1016/j.ijom.2011.12.016
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Statistically, significant numbers of central bone specimens of suppurative osteomyelitis of the jaws (SOJ), bisphosphonate induced osteonecrosis of the jaws (BIONJ), and osteoradionecrosis of the jaws (ORNJ) were compared. All three evidenced the common finding of necrotic bone with empty osteocytic lacunae, Haversian and Volkmann canals, but each showed a distinctive histopathologic pattern indicating a different disease mechanism and treatment options. Suppurative osteomyelitis was characterized by intense marrow inflammation and marrow vessel thrombosis with retention of viable osteoclasts and periosteum. Bisphosphonate induced osteonecrosis was characterized by an empty marrow space with empty Howship's lacunae and an absence of osteoclasts but viable periosteum. Osteoradionecrosis was characterized by a collagenous hypocellular, hypovascular marrow space and nonviable periosteum. Histologic evidence in SOJ indicates a microorganism provoked intense inflammation and marrow vascular thrombosis creating an environment conducive to continual bacterial proliferation. BIONJ is seen as a non-inflammatory drug toxicity to bone by osteoclastic death leading to over suppression of bone renewal, and ORN as another non-inflammatory condition caused by a high linear energy transfer that impairs or kills numerous cell types in the field of radiation including periosteum, bone, and all soft tissue.
引用
收藏
页码:283 / 289
页数:7
相关论文
共 11 条
  • [2] Antiremodeling agents influence osteoblast activity differently in modeling and remodeling sites of canine rib
    Allen, M. R.
    Follet, H.
    Khurana, M.
    Sato, M.
    Burr, D. B.
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2006, 79 (04) : 255 - 261
  • [3] Bisphosphonates do not inhibit periosteal bone formation in estrogen deficient animals and allow enhanced bone modeling in response to mechanical loading
    Feher, Anthony
    Koivunemi, Andrew
    Koivunemi, Mark
    Fuchs, Robyn K.
    Burr, David B.
    Phipps, Roger J.
    Reinwald, Susan
    Allen, Matthew R.
    [J]. BONE, 2010, 46 (01) : 203 - 207
  • [4] Kazuto M, 2009, J IMPLAM RECONSTR DE, V1
  • [5] Inhibition of oral mucosal cell wound healing by bisphosphonates
    Landesberg, Regina
    Cozin, Mattbew
    Cremers, Serge
    Woo, Victoria
    Kousteni, Stavroula
    Sinha, Satrajit
    Garrett-Sinha, LeeAnn
    Raghavan, Srikala
    [J]. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2008, 66 (05) : 839 - 847
  • [6] Martin TJ., 2000, Aust Prescriber, V23, P130
  • [7] OSTEORADIONECROSIS - A NEW CONCEPT OF ITS PATHO-PHYSIOLOGY
    MARX, RE
    [J]. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 1983, 41 (05) : 283 - 288
  • [8] Molecular mechanisms of action of bisphosphonates
    Rogers, MJ
    Frith, JC
    Luckman, SP
    Coxon, FP
    Benford, HL
    Mönkkönen, J
    Auriola, S
    Chilton, KM
    Russell, RGG
    [J]. BONE, 1999, 24 (05) : 73S - 79S
  • [9] RUBIN P, 1968, CLINICAL RADIATION P, V2, P557
  • [10] Bisphosphonates: Pharmacology, mechanisms of action and clinical uses
    Russell, RGG
    Croucher, PI
    Rogers, MJ
    [J]. OSTEOPOROSIS INTERNATIONAL, 1999, 9 (Suppl 2) : 66 - 80